17-1843952-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_002945.5(RPA1):c.117G>A(p.Pro39Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00205 in 1,613,806 control chromosomes in the GnomAD database, including 65 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 35 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 30 hom. )
Consequence
RPA1
NM_002945.5 synonymous
NM_002945.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.274
Genes affected
RPA1 (HGNC:10289): (replication protein A1) This gene encodes the largest subunit of the heterotrimeric Replication Protein A (RPA) complex, which binds to single-stranded DNA (ssDNA), forming a nucleoprotein complex that plays an important role in DNA metabolism, being involved in DNA replication, repair, recombination, telomere maintenance, and co-ordinating the cellular response to DNA damage through activation of the ataxia telangiectasia and Rad3-related protein (ATR) kinase. The nucleoprotein complex protects the single-stranded DNA from nucleases, prevents formation of secondary structures that would interfere with repair, and co-ordinates the recruitment and departure of different genome maintenance factors. This subunit contains four oligonucleotide/oligosaccharide-binding (OB) domains, though the majority of ssDNA binding occurs in two of these domains. The heterotrimeric complex has two different modes of ssDNA binding, a low-affinity and high-affinity mode, determined by which ssDNA binding domains are utilized. The different binding modes differ in the length of DNA bound and in the proteins with which it interacts, thereby playing a role in regulating different genomic maintenance pathways. [provided by RefSeq, Sep 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 17-1843952-G-A is Benign according to our data. Variant chr17-1843952-G-A is described in ClinVar as [Benign]. Clinvar id is 718296.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.274 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0109 (1663/152182) while in subpopulation AFR AF= 0.0372 (1545/41518). AF 95% confidence interval is 0.0357. There are 35 homozygotes in gnomad4. There are 803 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1663 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPA1 | NM_002945.5 | c.117G>A | p.Pro39Pro | synonymous_variant | 3/17 | ENST00000254719.10 | NP_002936.1 | |
RPA1 | NM_001355120.2 | c.78G>A | p.Pro26Pro | synonymous_variant | 3/17 | NP_001342049.1 | ||
RPA1 | NM_001355121.2 | c.117G>A | p.Pro39Pro | synonymous_variant | 3/16 | NP_001342050.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPA1 | ENST00000254719.10 | c.117G>A | p.Pro39Pro | synonymous_variant | 3/17 | 1 | NM_002945.5 | ENSP00000254719.4 | ||
RPA1 | ENST00000570451.5 | c.78G>A | p.Pro26Pro | synonymous_variant | 3/7 | 3 | ENSP00000459788.1 | |||
RPA1 | ENST00000571058.5 | c.78G>A | p.Pro26Pro | synonymous_variant | 3/6 | 4 | ENSP00000461733.1 | |||
RPA1 | ENST00000571725.1 | n.33G>A | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0109 AC: 1660AN: 152064Hom.: 35 Cov.: 31
GnomAD3 genomes
AF:
AC:
1660
AN:
152064
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00290 AC: 729AN: 251362Hom.: 14 AF XY: 0.00213 AC XY: 289AN XY: 135862
GnomAD3 exomes
AF:
AC:
729
AN:
251362
Hom.:
AF XY:
AC XY:
289
AN XY:
135862
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00113 AC: 1652AN: 1461624Hom.: 30 Cov.: 30 AF XY: 0.000996 AC XY: 724AN XY: 727134
GnomAD4 exome
AF:
AC:
1652
AN:
1461624
Hom.:
Cov.:
30
AF XY:
AC XY:
724
AN XY:
727134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0109 AC: 1663AN: 152182Hom.: 35 Cov.: 31 AF XY: 0.0108 AC XY: 803AN XY: 74406
GnomAD4 genome
AF:
AC:
1663
AN:
152182
Hom.:
Cov.:
31
AF XY:
AC XY:
803
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 05, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at